Obstetric history and antibody titer in estimating severity of Kell alloimmunization in pregnancy

Obstetrics and Gynecology

Volumn 109, Issue 5, 2007, Pages 1093-1098

  Van Wamelen, D J ^b   Klumper, F J ^b   De Haas, M ^b   Meerman, R H ^b   Van Kamp, I L ^b   Oepkes, D ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALLOANTIBODY; KELL ANTIBODY; MATERNAL ANTIBODY; UNCLASSIFIED DRUG;

ADULT; ALLOIMMUNIZATION; ANEMIA; ANTIBODY BLOOD LEVEL; ANTIBODY TITER; ARTICLE; BLOOD GROUP KELL SYSTEM; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; FEMALE; FETUS DISEASE; FETUS MONITORING; GESTATIONAL AGE; HUMAN; INTRAUTERINE BLOOD TRANSFUSION; MATERNAL SERUM; NEWBORN; PREGNANCY; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

BLOOD FLOW VELOCITY; BLOOD TRANSFUSION, INTRAUTERINE; ERYTHROBLASTOSIS, FETAL; FEMALE; FETAL BLOOD; GESTATIONAL AGE; HUMANS; KELL BLOOD-GROUP SYSTEM; MIDDLE CEREBRAL ARTERY; PREGNANCY; PREGNANCY OUTCOME; PREGNANCY, HIGH-RISK; RETROSPECTIVE STUDIES;

EID: 34247577630     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.AOG.0000260957.77090.4e     Document Type: Article

References (18)

1. Lee S, Russo D, Redman CM. Functional and structural aspects of the Kell blood group system. Transf Med Rev 2000;14:93-103.
2. Tovey LA. Haemolytic disease of the newborn: the changing scene. Br J Obstet Gynaecol 1986;93:960-6.
3. Geifman-Holtzman O, Wojtowycz M, Kosmas E, Artal R. Female alloimunization with antibodies known to cause hemolytic disease. Obstet Gynecol 1997;89:272-5.
4. Van Kamp IL, Klumper FJ, Meerman RH, Oepkes D, Scherjon SA, Kanhai HH. Treatment of fetal anemia due to red-cell alloimmunization with intrauterine transfusions in the Netherlands, 1988-1999. Acta Obstet Gynecol Scand 2004;83:731-7.
5. Moise KJ Jr. Hemolytic disease of the fetus and newborn. In: Creasy RK, Resnik R, Iams JD, editors. Maternal-fetal medicine: principles and practice. 5th ed. Philadelphia (PA): Saunders; 2004. p 537-61.
6. Van Dijk BA, Dooren MC, Overbeeke MAM. Red cell antibodies in pregnancy: there is no "critical titre". Transfus Med 1995;4:199-202.
7. Bowell PJ, Brown SE, Dike AE, Inskip MJ. The significance of anti-c alloimmunization in pregnancy. Br J Obstet Gynaecol 1986;93:1044-8.
8. Rodeck CH, Deans A. Red cell alloimmunisation. In: Rodeck CH, Whittle MJ, editors. Fetal medicine: basic science and clinical practice. London (UK): Churchill Livingstone; 1999. p. 785-804.
9. Nicolaides KH, Sebire NJ. Management of red cell isoimmunized pregnancies. In: Kurjak A, Chervernak FA, editors. Textbook of perinatal medicine. 2nd ed. Informa (UK): Oxon; 2006. p 1135-42.
10. Oepkes D, Brand R, Vandenbussche FP, Meerman RH, Kanhai HH. The use of ultrasonography and Doppler in the prediction of fetal haemolytic anaemia: a multivariate analysis. Br J Obstet Gynaecol 1994;101:680-4.
11. Nicolaides KH, Rodeck CH, Mibashan RS, Kemp JR. Have Liley charts outlived their usefulness? Am J Obstet Gynecol 1986;155:90-4.
12. Vaughan JI, Warwick R, Letsky E, Nicolini U, Rodeck CH, Fisk NM. Erythropoietic suppression in fetal anemia because of Kell alloimmunization. Am J Obstet Gynecol 1994;171:247-52.
13. Mari G. Noninvasive diagnosis by Doppler ultrasonography of fetal anemia due to maternal red-cell alloimmunization. Collaborative Group for Doppler Assessment of the Blood Velocity in Anemic Fetuses. N Engl J Med 2000;342:9-14.
14. Van Dongen H, Klumper FJCM, Sikkel E, Vandenbussche FP, Oepkes D. Ultrasound and Doppler in the prediction of fetal anemia in Kell alloimmunized pregnancies. Ultrasound Obstet Gynecol 2005;25:341-5.
15. Oepkes D, Seaward PG, Vandenbussche FP, Windrim R, Kingdom J, Beyene J, et al. Doppler ultrasonography versus amniocentesis to predict fetal anemia. N Engl J Med 2006;355:156-64.
16. Gottvall T, Hilden JO, Selbing A. Evaluation of standard parameters to predict exchange transfusions in the erythroblastotic newborn. Acta Obstet Gynecol Scand 1994;73:300-6.
17. Bowman J. Maternal Kell blood group alloimmunization. Obstet Gynecol 1992;79:39-44.
18. Castel A, Van Dijk BA, Van den Boom FMLG Brand A, Engelfriet CP, Overbeeke MAM, et al. Prevention of immunization by c, E and K: backgrounds and gradual implementation. Ned Tijdschr Klin Chem 1996;21:3-7.